Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report

被引:2
作者
Tobin, Morgan A. [1 ]
Dougherty, David F. [2 ]
Ratliff, Patrick D. [1 ]
Judd, W. Russ [1 ]
机构
[1] St Joseph Hosp, Dept Pharm Serv, One St Joseph Dr, Lexington, KY 40504 USA
[2] St Joseph Hosp, Lexington Infect Dis Consultants, Lexington, KY USA
关键词
hyperinfection syndrome; meningitis; strongyloides; Strongyloides stercoralis; strongyloidiasis; vancomycin-resistant enterococcus; INFECTIONS;
D O I
10.1111/jcpt.13448
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective: The rhabditid nematode Strongyloides stercoralis is the major causative agent of disseminated strongyloidiasis (DS). In rare cases, DS has caused enterococcal meningitis. If DS-associated vancomycin-resistant Enterococcus faecium (VRE) meningitis is suspected, combination antibiotic therapy should be considered. Case Summary: We present a case of a 61-year-old male who developed DS associated with vancomycin-resistant and linezolid-intermediate E. faecium meningitis after receiving corticosteroids. The VRE meningitis was treated with high-dose daptomycin 12 mg/kg, linezolid, tigecycline and quinupristin/dalfopristin. Despite negative cultures, the patient expired. What is new and conclusion: In patients with DS-associated VRE meningitis, early use of combination therapy may be warranted to improve patient outcomes.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 17 条
[1]   Strongyloides hyperinfection syndrome presenting as enterococcal meningitis in a low-endemicity area [J].
Bamias, Giorgos ;
Toskas, Aggelos ;
Psychogiou, Mina ;
Delladetsima, Ioanna ;
Siakavellas, Spyros I. ;
Dimarogona, Kiriaki ;
Daikos, George L. .
VIRULENCE, 2010, 1 (05) :468-470
[2]   Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model [J].
Cottagnoud, P ;
Gerber, CM ;
Acosta, F ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :981-985
[3]  
Global Health Division of Parasitic Diseases and Malaria, 2020, STRONG 2018
[4]   Strongyloidiasis A Neglected Tropical Disease [J].
Krolewiecki, Alejandro ;
Nutman, Thomas B. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (01) :135-+
[5]   Disseminated strongyloidiasis: a retrospective study of clinical course and outcome [J].
Lam, CS ;
Tong, MKH ;
Chan, KM ;
Siu, YP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) :14-18
[6]  
McCannon JB., 2020, AM J RESP CRIT CARE, V201, pA6471
[7]   Combatting resistant enterococcal infections: a pharmacotherapy review [J].
Mercuro, Nicholas J. ;
Davis, Susan L. ;
Zervos, Marcus J. ;
Herc, Erica S. .
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (09) :979-992
[8]  
Najmuddin Asif, 2012, W V Med J, V108, P32
[9]   Intrathecal Antibacterial and Antifungal Therapies [J].
Nau, Roland ;
Blei, Claudia ;
Eiffert, Helmut .
CLINICAL MICROBIOLOGY REVIEWS, 2020, 33 (03)
[10]   Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections [J].
Nau, Roland ;
Soergel, Fritz ;
Eiffert, Helmut .
CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (04) :858-+